Bioorthogonal Compositions (2018)
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 2 of these applications claim priority to application PCT/US2016/051394, filed Sep 12, 2016. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 10,828,373 | Bioorthogonal Compositions In force · High confidence | Tambo, Inc. | In force | High confidence | ||
| US 12,527,874 | Bioorthogonal Compositions In force · High confidence | Tambo, Inc. | In force | High confidence | ||
| Application 17/032,966 | Bioorthogonal Compositions Abandoned Abandoned Feb 7, 2022 | Tambo, Inc. | Abandoned | Abandoned Feb 7, 2022 | ||
| Application 18/912,814 | Bioorthogonal Compositions Pending Not granted | Tambo, Inc. | Pending | Not granted |
4 of 4 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
2 of these are in force and held by Tambo, Inc..
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.